ArticleJournal of medicinal chemistry2020

Novel Pyrrolopyridone Bromodomain and Extra-Terminal Motif (BET) Inhibitors Effective in Endocrine-Resistant ER+ Breast Cancer with Acquired Resistance to Fulvestrant and Palbociclib.

Yangfeng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.